Just Biotherapeutics pulls in $14M Series A2 funding
July 26, 2016
Founded in 2014, Just Biotherapeutics is an integrated design company that works to develop biotherapeutics through the use of molecular, process, drug product and manufacturing plant design. This round follows a $15 million financing last September which valued the company at $45.7 million. The fresh funds will allow the company to complete a new lab space and pilot plant.